Yixintang Pharmaceutical Group Co., Ltd. (002727.SZ)
CNY 13.93
(-0.5%)
CNY 13.93
(-0.5%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 549.44 Million CNY | -45.6% |
| 2022 | 1 Billion CNY | 9.59% |
| 2021 | 921.58 Million CNY | 16.66% |
| 2020 | 789.96 Million CNY | 30.81% |
| 2019 | 603.91 Million CNY | 15.9% |
| 2018 | 521.06 Million CNY | 23.27% |
| 2017 | 422.71 Million CNY | 19.62% |
| 2016 | 353.37 Million CNY | 2.0% |
| 2015 | 346.43 Million CNY | 16.52% |
| 2014 | 297.3 Million CNY | 23.44% |
| 2013 | 240.85 Million CNY | 31.94% |
| 2012 | 182.55 Million CNY | 35.51% |
| 2011 | 134.7 Million CNY | 30.86% |
| 2010 | 102.94 Million CNY | 21.33% |
| 2009 | 84.84 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 10.59 Million CNY | -73.49% |
| 2024 Q1 | 241.91 Million CNY | 277.26% |
| 2024 Q2 | 39.98 Million CNY | -83.47% |
| 2023 Q4 | -136.47 Million CNY | -175.26% |
| 2023 Q1 | 239.46 Million CNY | -28.01% |
| 2023 Q2 | 265.11 Million CNY | 10.71% |
| 2023 FY | 549.44 Million CNY | -45.6% |
| 2023 Q3 | 181.34 Million CNY | -31.6% |
| 2022 Q1 | 179.38 Million CNY | 13.76% |
| 2022 FY | 1 Billion CNY | 9.59% |
| 2022 Q4 | 332.63 Million CNY | 28.37% |
| 2022 Q3 | 259.12 Million CNY | 8.48% |
| 2022 Q2 | 238.86 Million CNY | 33.16% |
| 2021 FY | 921.58 Million CNY | 16.66% |
| 2021 Q4 | 157.67 Million CNY | -34.31% |
| 2021 Q3 | 240.03 Million CNY | -8.82% |
| 2021 Q2 | 263.23 Million CNY | 1.0% |
| 2021 Q1 | 260.63 Million CNY | 40.26% |
| 2020 Q3 | 187.78 Million CNY | -11.25% |
| 2020 FY | 789.96 Million CNY | 30.81% |
| 2020 Q1 | 204.77 Million CNY | 70.89% |
| 2020 Q2 | 211.58 Million CNY | 3.32% |
| 2020 Q4 | 185.82 Million CNY | -1.04% |
| 2019 Q4 | 119.82 Million CNY | -18.4% |
| 2019 FY | 603.91 Million CNY | 15.9% |
| 2019 Q3 | 146.85 Million CNY | -9.31% |
| 2019 Q2 | 161.92 Million CNY | -7.64% |
| 2019 Q1 | 175.31 Million CNY | 70.98% |
| 2018 Q2 | 161.14 Million CNY | 22.72% |
| 2018 Q1 | 131.31 Million CNY | 23.02% |
| 2018 FY | 521.06 Million CNY | 23.27% |
| 2018 Q4 | 102.53 Million CNY | -18.68% |
| 2018 Q3 | 126.07 Million CNY | -21.76% |
| 2017 Q2 | 118.88 Million CNY | 22.23% |
| 2017 Q1 | 97.26 Million CNY | 39.98% |
| 2017 FY | 422.71 Million CNY | 19.62% |
| 2017 Q4 | 106.74 Million CNY | 6.93% |
| 2017 Q3 | 99.82 Million CNY | -16.03% |
| 2016 Q1 | 105.71 Million CNY | 11.19% |
| 2016 Q2 | 90.57 Million CNY | -14.32% |
| 2016 FY | 353.37 Million CNY | 2.0% |
| 2016 Q3 | 87.5 Million CNY | -3.4% |
| 2016 Q4 | 69.48 Million CNY | -20.59% |
| 2015 Q4 | 95.07 Million CNY | 22.86% |
| 2015 FY | 346.43 Million CNY | 16.52% |
| 2015 Q2 | 83.39 Million CNY | -7.93% |
| 2015 Q1 | 90.58 Million CNY | 25.93% |
| 2015 Q3 | 77.38 Million CNY | -7.21% |
| 2014 Q2 | 79.45 Million CNY | 1.75% |
| 2014 FY | 297.3 Million CNY | 23.44% |
| 2014 Q4 | 71.93 Million CNY | 6.04% |
| 2014 Q3 | 67.83 Million CNY | -14.63% |
| 2014 Q1 | 78.08 Million CNY | 17.83% |
| 2013 Q4 | 66.27 Million CNY | 21.15% |
| 2013 FY | 240.85 Million CNY | 31.94% |
| 2013 Q2 | 53.83 Million CNY | -18.49% |
| 2013 Q3 | 54.7 Million CNY | 1.61% |
| 2013 Q1 | 66.04 Million CNY | 0.0% |
| 2012 FY | 182.55 Million CNY | 35.51% |
| 2011 FY | 134.7 Million CNY | 30.86% |
| 2010 FY | 102.94 Million CNY | 21.33% |
| 2009 FY | 84.84 Million CNY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Cachet Pharmaceutical Co., Ltd. | 250.06 Million CNY | -119.724% |
| ZJAMP Group Co., Ltd. | 380.94 Million CNY | -44.231% |
| Luyan Pharma Co.,Ltd. | 363.53 Million CNY | -51.14% |
| Ji Yao Holding Group Co., Ltd. | -349.3 Million CNY | 257.294% |